Therapeutic Advances in Musculoskeletal Disease-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2149597, encodeId=bac9214959ea2, content=我的投稿从The Editor is assessing your submission for peer review转换到Reviewers are being assigned and comments are being collected很多次了，已经投稿2个月了，请问有没有人知道这是什么原因啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36524839572, createdName=1884422f6bm, createdTime=Mon Jul 24 16:34:42 CST 2023, time=2023-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2167790, encodeId=0d3f216e7900a, content=和几位日韩的同行聊到过这本期刊，很认可，国际知名度可以。感觉国内知名度很一般。尝试投了1篇，一审1个半月，二审也是1个半月后接收，速度不算快，但审稿很认真，质量有保证，继续保持。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ab8211389, createdName=ms8000000020899315, createdTime=Fri Nov 10 11:00:35 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167003, encodeId=a8f2216e0035e, content=偶然间关注到这本杂志，文章质量真不错，就是年发文量有点少，中国作者的发文量也很少，估计是有点严苛，重要的是不用担心上黑名单倒是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bda6389702, createdName=MS455555222, createdTime=Mon Nov 06 14:07:42 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166331, encodeId=151d216633181, content=关注这本杂志很久了，IF和文章质量都在逐步提升，对中国作者也比较友好，文章涵盖面广，审稿速度适中，下一篇文章准备试试投他们家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Thu Nov 02 17:38:14 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1107202, encodeId=1944110e2020f, content=想要做但未做的实验是否可以放到讨论中？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107201, encodeId=e023110e20175, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812208, encodeId=684e81220848, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审巨慢，五个多月。不过二审倒挺快，不到一个月。因为杂志的专业性比较强，所以审稿人都是小同行，比较专业，提了很多非常好的建议。年文章量太少，就30+。更正一个系统里的错误，这个杂志是OA，不是非OA。版面费2200USD。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02422346604, createdName=TAZ牙医, createdTime=Sun Aug 23 03:20:34 CST 2020, time=2020-08-23, status=1, ipAttribution=)]

2023-07-24 1884422f6bm 来自江苏省

我的投稿从The Editor is assessing your submission for peer review转换到Reviewers are being assigned and comments are being collected很多次了，已经投稿2个月了，请问有没有人知道这是什么原因啊？

29 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2149597, encodeId=bac9214959ea2, content=我的投稿从The Editor is assessing your submission for peer review转换到Reviewers are being assigned and comments are being collected很多次了，已经投稿2个月了，请问有没有人知道这是什么原因啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36524839572, createdName=1884422f6bm, createdTime=Mon Jul 24 16:34:42 CST 2023, time=2023-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2167790, encodeId=0d3f216e7900a, content=和几位日韩的同行聊到过这本期刊，很认可，国际知名度可以。感觉国内知名度很一般。尝试投了1篇，一审1个半月，二审也是1个半月后接收，速度不算快，但审稿很认真，质量有保证，继续保持。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ab8211389, createdName=ms8000000020899315, createdTime=Fri Nov 10 11:00:35 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167003, encodeId=a8f2216e0035e, content=偶然间关注到这本杂志，文章质量真不错，就是年发文量有点少，中国作者的发文量也很少，估计是有点严苛，重要的是不用担心上黑名单倒是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bda6389702, createdName=MS455555222, createdTime=Mon Nov 06 14:07:42 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166331, encodeId=151d216633181, content=关注这本杂志很久了，IF和文章质量都在逐步提升，对中国作者也比较友好，文章涵盖面广，审稿速度适中，下一篇文章准备试试投他们家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Thu Nov 02 17:38:14 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1107202, encodeId=1944110e2020f, content=想要做但未做的实验是否可以放到讨论中？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107201, encodeId=e023110e20175, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812208, encodeId=684e81220848, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审巨慢，五个多月。不过二审倒挺快，不到一个月。因为杂志的专业性比较强，所以审稿人都是小同行，比较专业，提了很多非常好的建议。年文章量太少，就30+。更正一个系统里的错误，这个杂志是OA，不是非OA。版面费2200USD。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02422346604, createdName=TAZ牙医, createdTime=Sun Aug 23 03:20:34 CST 2020, time=2020-08-23, status=1, ipAttribution=)]

2023-11-10 ms8000000020899315 来自上海

和几位日韩的同行聊到过这本期刊，很认可，国际知名度可以。感觉国内知名度很一般。尝试投了1篇，一审1个半月，二审也是1个半月后接收，速度不算快，但审稿很认真，质量有保证，继续保持。

26 0

[GetPortalCommentsPageByObjectIdResponse(id=2149597, encodeId=bac9214959ea2, content=我的投稿从The Editor is assessing your submission for peer review转换到Reviewers are being assigned and comments are being collected很多次了，已经投稿2个月了，请问有没有人知道这是什么原因啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36524839572, createdName=1884422f6bm, createdTime=Mon Jul 24 16:34:42 CST 2023, time=2023-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2167790, encodeId=0d3f216e7900a, content=和几位日韩的同行聊到过这本期刊，很认可，国际知名度可以。感觉国内知名度很一般。尝试投了1篇，一审1个半月，二审也是1个半月后接收，速度不算快，但审稿很认真，质量有保证，继续保持。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ab8211389, createdName=ms8000000020899315, createdTime=Fri Nov 10 11:00:35 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167003, encodeId=a8f2216e0035e, content=偶然间关注到这本杂志，文章质量真不错，就是年发文量有点少，中国作者的发文量也很少，估计是有点严苛，重要的是不用担心上黑名单倒是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bda6389702, createdName=MS455555222, createdTime=Mon Nov 06 14:07:42 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166331, encodeId=151d216633181, content=关注这本杂志很久了，IF和文章质量都在逐步提升，对中国作者也比较友好，文章涵盖面广，审稿速度适中，下一篇文章准备试试投他们家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Thu Nov 02 17:38:14 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1107202, encodeId=1944110e2020f, content=想要做但未做的实验是否可以放到讨论中？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107201, encodeId=e023110e20175, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812208, encodeId=684e81220848, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审巨慢，五个多月。不过二审倒挺快，不到一个月。因为杂志的专业性比较强，所以审稿人都是小同行，比较专业，提了很多非常好的建议。年文章量太少，就30+。更正一个系统里的错误，这个杂志是OA，不是非OA。版面费2200USD。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02422346604, createdName=TAZ牙医, createdTime=Sun Aug 23 03:20:34 CST 2020, time=2020-08-23, status=1, ipAttribution=)]

2023-11-06 MS455555222 来自上海

偶然间关注到这本杂志，文章质量真不错，就是年发文量有点少，中国作者的发文量也很少，估计是有点严苛，重要的是不用担心上黑名单倒是真的

24 0

[GetPortalCommentsPageByObjectIdResponse(id=2149597, encodeId=bac9214959ea2, content=我的投稿从The Editor is assessing your submission for peer review转换到Reviewers are being assigned and comments are being collected很多次了，已经投稿2个月了，请问有没有人知道这是什么原因啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36524839572, createdName=1884422f6bm, createdTime=Mon Jul 24 16:34:42 CST 2023, time=2023-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2167790, encodeId=0d3f216e7900a, content=和几位日韩的同行聊到过这本期刊，很认可，国际知名度可以。感觉国内知名度很一般。尝试投了1篇，一审1个半月，二审也是1个半月后接收，速度不算快，但审稿很认真，质量有保证，继续保持。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ab8211389, createdName=ms8000000020899315, createdTime=Fri Nov 10 11:00:35 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167003, encodeId=a8f2216e0035e, content=偶然间关注到这本杂志，文章质量真不错，就是年发文量有点少，中国作者的发文量也很少，估计是有点严苛，重要的是不用担心上黑名单倒是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bda6389702, createdName=MS455555222, createdTime=Mon Nov 06 14:07:42 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166331, encodeId=151d216633181, content=关注这本杂志很久了，IF和文章质量都在逐步提升，对中国作者也比较友好，文章涵盖面广，审稿速度适中，下一篇文章准备试试投他们家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Thu Nov 02 17:38:14 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1107202, encodeId=1944110e2020f, content=想要做但未做的实验是否可以放到讨论中？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107201, encodeId=e023110e20175, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812208, encodeId=684e81220848, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审巨慢，五个多月。不过二审倒挺快，不到一个月。因为杂志的专业性比较强，所以审稿人都是小同行，比较专业，提了很多非常好的建议。年文章量太少，就30+。更正一个系统里的错误，这个杂志是OA，不是非OA。版面费2200USD。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02422346604, createdName=TAZ牙医, createdTime=Sun Aug 23 03:20:34 CST 2020, time=2020-08-23, status=1, ipAttribution=)]

2023-11-02 乌云背后的幸福线来自上海

关注这本杂志很久了，IF和文章质量都在逐步提升，对中国作者也比较友好，文章涵盖面广，审稿速度适中，下一篇文章准备试试投他们家

24 0

[GetPortalCommentsPageByObjectIdResponse(id=2149597, encodeId=bac9214959ea2, content=我的投稿从The Editor is assessing your submission for peer review转换到Reviewers are being assigned and comments are being collected很多次了，已经投稿2个月了，请问有没有人知道这是什么原因啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36524839572, createdName=1884422f6bm, createdTime=Mon Jul 24 16:34:42 CST 2023, time=2023-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2167790, encodeId=0d3f216e7900a, content=和几位日韩的同行聊到过这本期刊，很认可，国际知名度可以。感觉国内知名度很一般。尝试投了1篇，一审1个半月，二审也是1个半月后接收，速度不算快，但审稿很认真，质量有保证，继续保持。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ab8211389, createdName=ms8000000020899315, createdTime=Fri Nov 10 11:00:35 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167003, encodeId=a8f2216e0035e, content=偶然间关注到这本杂志，文章质量真不错，就是年发文量有点少，中国作者的发文量也很少，估计是有点严苛，重要的是不用担心上黑名单倒是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bda6389702, createdName=MS455555222, createdTime=Mon Nov 06 14:07:42 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166331, encodeId=151d216633181, content=关注这本杂志很久了，IF和文章质量都在逐步提升，对中国作者也比较友好，文章涵盖面广，审稿速度适中，下一篇文章准备试试投他们家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Thu Nov 02 17:38:14 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1107202, encodeId=1944110e2020f, content=想要做但未做的实验是否可以放到讨论中？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107201, encodeId=e023110e20175, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812208, encodeId=684e81220848, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审巨慢，五个多月。不过二审倒挺快，不到一个月。因为杂志的专业性比较强，所以审稿人都是小同行，比较专业，提了很多非常好的建议。年文章量太少，就30+。更正一个系统里的错误，这个杂志是OA，不是非OA。版面费2200USD。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02422346604, createdName=TAZ牙医, createdTime=Sun Aug 23 03:20:34 CST 2020, time=2020-08-23, status=1, ipAttribution=)]

2021-12-29 msSSSSSD

想要做但未做的实验是否可以放到讨论中？

56 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2149597, encodeId=bac9214959ea2, content=我的投稿从The Editor is assessing your submission for peer review转换到Reviewers are being assigned and comments are being collected很多次了，已经投稿2个月了，请问有没有人知道这是什么原因啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36524839572, createdName=1884422f6bm, createdTime=Mon Jul 24 16:34:42 CST 2023, time=2023-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2167790, encodeId=0d3f216e7900a, content=和几位日韩的同行聊到过这本期刊，很认可，国际知名度可以。感觉国内知名度很一般。尝试投了1篇，一审1个半月，二审也是1个半月后接收，速度不算快，但审稿很认真，质量有保证，继续保持。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ab8211389, createdName=ms8000000020899315, createdTime=Fri Nov 10 11:00:35 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167003, encodeId=a8f2216e0035e, content=偶然间关注到这本杂志，文章质量真不错，就是年发文量有点少，中国作者的发文量也很少，估计是有点严苛，重要的是不用担心上黑名单倒是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bda6389702, createdName=MS455555222, createdTime=Mon Nov 06 14:07:42 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166331, encodeId=151d216633181, content=关注这本杂志很久了，IF和文章质量都在逐步提升，对中国作者也比较友好，文章涵盖面广，审稿速度适中，下一篇文章准备试试投他们家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Thu Nov 02 17:38:14 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1107202, encodeId=1944110e2020f, content=想要做但未做的实验是否可以放到讨论中？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107201, encodeId=e023110e20175, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812208, encodeId=684e81220848, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审巨慢，五个多月。不过二审倒挺快，不到一个月。因为杂志的专业性比较强，所以审稿人都是小同行，比较专业，提了很多非常好的建议。年文章量太少，就30+。更正一个系统里的错误，这个杂志是OA，不是非OA。版面费2200USD。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02422346604, createdName=TAZ牙医, createdTime=Sun Aug 23 03:20:34 CST 2020, time=2020-08-23, status=1, ipAttribution=)]

2021-12-28 Mia

模式图一般放在讨论中展示还是放在结果部分？

53 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2149597, encodeId=bac9214959ea2, content=我的投稿从The Editor is assessing your submission for peer review转换到Reviewers are being assigned and comments are being collected很多次了，已经投稿2个月了，请问有没有人知道这是什么原因啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36524839572, createdName=1884422f6bm, createdTime=Mon Jul 24 16:34:42 CST 2023, time=2023-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2167790, encodeId=0d3f216e7900a, content=和几位日韩的同行聊到过这本期刊，很认可，国际知名度可以。感觉国内知名度很一般。尝试投了1篇，一审1个半月，二审也是1个半月后接收，速度不算快，但审稿很认真，质量有保证，继续保持。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ab8211389, createdName=ms8000000020899315, createdTime=Fri Nov 10 11:00:35 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167003, encodeId=a8f2216e0035e, content=偶然间关注到这本杂志，文章质量真不错，就是年发文量有点少，中国作者的发文量也很少，估计是有点严苛，重要的是不用担心上黑名单倒是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bda6389702, createdName=MS455555222, createdTime=Mon Nov 06 14:07:42 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166331, encodeId=151d216633181, content=关注这本杂志很久了，IF和文章质量都在逐步提升，对中国作者也比较友好，文章涵盖面广，审稿速度适中，下一篇文章准备试试投他们家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Thu Nov 02 17:38:14 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1107202, encodeId=1944110e2020f, content=想要做但未做的实验是否可以放到讨论中？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107201, encodeId=e023110e20175, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812208, encodeId=684e81220848, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审巨慢，五个多月。不过二审倒挺快，不到一个月。因为杂志的专业性比较强，所以审稿人都是小同行，比较专业，提了很多非常好的建议。年文章量太少，就30+。更正一个系统里的错误，这个杂志是OA，不是非OA。版面费2200USD。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02422346604, createdName=TAZ牙医, createdTime=Sun Aug 23 03:20:34 CST 2020, time=2020-08-23, status=1, ipAttribution=)]

2020-08-23 TAZ牙医

审稿速度:6.0 | 投稿命中率:25.0
经验分享：一审巨慢，五个多月。不过二审倒挺快，不到一个月。因为杂志的专业性比较强，所以审稿人都是小同行，比较专业，提了很多非常好的建议。年文章量太少，就30+。更正一个系统里的错误，这个杂志是OA，不是非OA。版面费2200USD。

80 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务